{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:49:55Z","timestamp":1768362595789,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.critrevonc.2025.105050","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:20:46Z","timestamp":1763911246000},"page":"105050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The relationship between circulating tumor biomarkers and prognosis of appendix cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"217","author":[{"given":"Yiyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6338-9696","authenticated-orcid":false,"given":"Shiyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2025.105050_bib1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1245\/s10434-016-5717-y","article-title":"Use of tumor markers in gastrointestinal cancers: surgeon perceptions and cost-benefit trade-off analysis","volume":"24","author":"Acharya","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105050_bib2","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1177\/0962280218811349","article-title":"Meta-analysis of non-statistically significant unreported effects","volume":"28","author":"Albajes-Eizagirre","year":"2019","journal-title":"Stat. Methods Med. Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105050_bib3","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/cas.14189","article-title":"Prognostic value of blood and lymphatic vessel markers in tongue cancer: a systematic review","volume":"110","author":"Almahmoudi","year":"2019","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105050_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105050_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","article-title":"Predicting survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendix adenocarcinoma","volume":"61","author":"Aziz","year":"2018","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41598-020-57930-x","article-title":"CA19-9 for detecting recurrence of pancreatic cancer","volume":"10","author":"Azizian","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105050_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jso.26671","article-title":"Nomogram to predict overall survival of patients with pseudomyxoma peritonei of appendiceal origin: a retrospective cohort study","volume":"124","author":"Bai","year":"2021","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","article-title":"Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Baratti","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1245\/s10434-017-6252-1","article-title":"Validation of the recent PSOGI pathological classification of Pseudomyxoma peritonei in a single-center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Baratti","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105050_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ijgc-00009577-200511001-00015","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105050_bib11","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1245\/s10434-018-6561-z","article-title":"Preoperative circulating tumor DNA in patients with peritoneal carcinomatosis is an independent predictor of progression-free survival","volume":"25","author":"Baumgartner","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105050_bib12","article-title":"Multi-institutional study evaluating the role of circulating tumor DNA in the management of appendiceal cancers","volume":"8","author":"Belmont","year":"2024","journal-title":"JCO Precis. Oncol."},{"issue":"224","key":"10.1016\/j.critrevonc.2025.105050_bib13","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105050_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1245\/s10434-011-1714-3","article-title":"Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients","volume":"18","author":"Chua","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105050_bib16","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"Chua","year":"2012","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib18","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14740\/wjon1425","article-title":"Carcinoembryonic antigen, carbohydrate antigen 19-9, cancer antigen 125, prostate-specific antigen and other cancer markers: a primer on commonly used cancer markers","volume":"14","author":"Desai","year":"2023","journal-title":"World J. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105050_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1568009623666230320121332","article-title":"Pathological implications of mucin signaling in metastasis","volume":"23","author":"Dhanisha","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105050_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jso.27178","article-title":"Cancer embryonic antigen (CEA) levels in patients with appendiceal adenocarcinoma predict response to neo-adjuvant chemotherapy and overall survival","volume":"127","author":"Egbert","year":"2023","journal-title":"J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105050_bib22","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1007\/s11605-021-04953-y","article-title":"The utility of preoperative tumor markers in peritoneal carcinomatosis from primary appendiceal adenocarcinoma: an analysis from the US HIPEC collaborative","volume":"25","author":"Fackche","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.critrevonc.2025.105050_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Felder","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1245\/s10434-016-5588-2","article-title":"Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up","volume":"24","author":"Fournier","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105050_bib25","article-title":"Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement","author":"Godfrey","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"30","key":"10.1016\/j.critrevonc.2025.105050_bib26","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.3748\/wjg.v17.i30.3531","article-title":"Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry","volume":"17","author":"Guo","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105050_bib27","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/jcm11102840","article-title":"Current trends in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal disease from appendiceal and colorectal malignancies","volume":"11","author":"Harper","year":"2022","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib28","first-page":"590","article-title":"Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer","volume":"73","author":"Janczewski","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105050_bib29","first-page":"189","article-title":"Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression","volume":"30","author":"Kannagi","year":"2007","journal-title":"Chang Gung Med. J."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105050_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/CBM-160662","article-title":"Prognostic factors for survival in advanced appendiceal cancers","volume":"17","author":"Khan","year":"2016","journal-title":"Cancer Biomark."},{"issue":"31-32","key":"10.1016\/j.critrevonc.2025.105050_bib31","first-page":"519","article-title":"Neoplasms of the appendix","volume":"120","author":"K\u00f6hler","year":"2023","journal-title":"Dtsch Arztebl Int."},{"key":"10.1016\/j.critrevonc.2025.105050_bib32","doi-asserted-by":"crossref","unstructured":"Kothary,\u00a0V.,\u00a0et al.,\u00a02022.\u00a0Correlation of circulating tumor DNA (ctDNA) with clinical outcomes in appendiceal cancers (AC). In:\u00a0Journal of Clinical Oncology. Conference, 40. doi:10.1200\/JCO.2023.41.4_suppl.226.","DOI":"10.1200\/JCO.2022.40.4_suppl.029"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/JCMA.0000000000000730","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on low-grade appendiceal mucinous neoplasm: a single tertiary hospital experience","volume":"85","author":"Kuan","year":"2022","journal-title":"J. Chin. Med. Assoc."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.23329","article-title":"Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei","volume":"108","author":"Kusamura","year":"2013","journal-title":"J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105050_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204056","article-title":"Bias caused by sampling error in meta-analysis with small sample sizes","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105050_bib36","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.18632\/oncotarget.6819","article-title":"Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105050_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00384-020-03828-z","article-title":"Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy","volume":"36","author":"Liu","year":"2021","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.critrevonc.2025.105050_bib38","doi-asserted-by":"crossref","first-page":"1081655","DOI":"10.3389\/fonc.2023.1081655","article-title":"Prognostic value of nectin-4 in human cancerS: A meta-analysis","volume":"13","author":"Liu","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105050_bib39","doi-asserted-by":"crossref","unstructured":"Management of Appendiceal Neoplasms (2025). 2025. doi: 10.1097\/DCR.0000000000003796.","DOI":"10.1097\/DCR.0000000000003796"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105050_bib40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00595-021-02248-y","article-title":"Prognostic impact of CEA\/CA19-9 at the time of recurrence in patients with gastric cancer","volume":"51","author":"Moriyama","year":"2021","journal-title":"Surg. Today"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105050_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102390","article-title":"Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis","volume":"9","author":"Nader-Marta","year":"2024","journal-title":"ESMO Open"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s13304-023-01587-4","article-title":"Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas","volume":"75","author":"Napoli","year":"2023","journal-title":"Updates Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105050_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11605-021-05075-1","article-title":"Prognostic significance of preoperative tumor markers in pseudomyxoma peritonei from low-grade appendiceal mucinous neoplasm: a study from the US HIPEC collaborative","volume":"26","author":"Nizam","year":"2022","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Trac."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105050_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrac103","article-title":"Demographic trends in the incidence of malignant appendiceal tumours in England between 1995 and 2016: population-based analysis","volume":"6","author":"Orchard","year":"2022","journal-title":"BJS Open"},{"key":"10.1016\/j.critrevonc.2025.105050_bib46","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2025.105050_bib47","author":"Radua","year":"2020","journal-title":"Package \u2018metansue\u2019"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105050_bib48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/02656736.2017.1384073","article-title":"The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin","volume":"34","author":"Rangarajan","year":"2018","journal-title":"Int. J. Hyperth."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105050_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24670","article-title":"Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma","volume":"36","author":"Rashedi","year":"2022","journal-title":"J. Clin. Lab Anal."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.105050_bib50","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1245\/s10434-024-16254-0","article-title":"Reclassification of appendiceal mucinous neoplasms and associated pseudomyxoma peritonei according to the peritoneal surface oncology group international consensus: clinicopathological reflections of a two-center cohort study","volume":"31","author":"Rauwerdink","year":"2024","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105050_bib51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1245\/s10434-017-6310-8","article-title":"Histologic predictors of recurrence in mucinous appendiceal tumors with peritoneal dissemination after HIPEC","volume":"25","author":"Reghunathan","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105050_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/COC.0000000000000210","article-title":"Incidence and survival of appendiceal mucinous neoplasms: a SEER analysis","volume":"40","author":"Shaib","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105050_bib54","article-title":"Network meta-analysis: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.critrevonc.2025.105050_bib55","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105050_bib56","first-page":"515","article-title":"Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma peritonei: analysis of 519 patients","volume":"40","author":"Taflampas","year":"2014","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105050_bib57","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.32881","article-title":"Management of appendiceal neoplasms","volume":"126","author":"The Chicago Consensus on peritoneal surface malignancies","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.105050_bib58","author":"van Valkenhoef","year":"2016","journal-title":"Package \u2018gemtc\u2019"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","article-title":"Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin","volume":"20","author":"Wagner","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105050_bib60","unstructured":"Wells, G.A., et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105050_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1078-0432.CCR-24-2474","article-title":"The landscape of ctDNA in Appendiceal adenocarcinoma","volume":"31","author":"White","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105050_bib62","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.31557\/APJCP.2024.25.6.1921","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as an early prognostic marker in patients with ovarian cancer: a systematic review and meta-analysis","volume":"25","author":"Winata","year":"2024","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105050_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/08941939.2019.1695986","article-title":"Analysis of clinical characteristics of low-grade appendiceal mucinous neoplasm (LAMN): a retrospective cohort study of 51 LAMN patients","volume":"34","author":"Xiao","year":"2021","journal-title":"J. Invest. Surg."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105050_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158002","article-title":"Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105050_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0260","article-title":"Serum tumor markers and outcomes in patients with Appendiceal adenocarcinoma","volume":"7","author":"Yousef","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"Supplement 4","key":"10.1016\/j.critrevonc.2025.105050_bib66","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1016\/j.annonc.2022.04.452","article-title":"Measurement of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma (AA): Prevalence, predictors, and correlation with clinical outcome","volume":"33","author":"Zeineddine","year":"2022","journal-title":"Ann. Oncol."},{"issue":"4 Supplement","key":"10.1016\/j.critrevonc.2025.105050_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2023.41.4_suppl.226","article-title":"Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA)","volume":"41","author":"Zeineddine","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105050_bib68","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ejso.2019.08.004","article-title":"Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication","volume":"45","author":"Zhang","year":"2019","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500438X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500438X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:41:50Z","timestamp":1768333310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282500438X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"alternative-id":["S104084282500438X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105050","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between circulating tumor biomarkers and prognosis of appendix cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105050"}}